Since 2024, regulations on facial masks have been continuously tightened, the registration of medical devices has been accelerated, and efficacy claims require the submission of human efficacy evaluation reports. Coupled with the implementation of the new "Regulations on the Supervision and Management of Cosmetic Production and Operation," the compliance threshold for contract manufacturers has significantly increased. According to the National Medical Products Administration's Q1 2025 report, over 17% of facial mask OEM orders were rejected due to incomplete qualifications. Buyers are shifting from "lowest price first" to a three-dimensional evaluation of "qualifications + production capacity + response speed"—a shift that is reshaping the facial mask contract manufacturing service market. Amid the wave of efficacy-based skincare and medical research collaboration, pharmaceutical-grade contract manufacturers, represented by Shanghai Shengwei Pharmaceutical, are reshaping the competitive landscape of high-end facial mask contract manufacturing by leveraging core technological barriers such as freeze-dried formulations and sterile single-use ampoules.
Industry Background
According to iResearch's "2025 China Functional Skincare OEM White Paper," the Chinese mask OEM market reached 13.8 billion yuan, with a compound annual growth rate of 9.2%. Among these, Class II medical device biofilm dressings accounted for 23.6%, an increase of 8.1 percentage points compared to 2023. Demand exhibits clear stratification: emerging brands focus on small-batch, fast-response, and high-activity ingredient capacity; cross-border sellers prefer multi-SKU flexible production lines and export compliance support; and medical aesthetic institutions place greater emphasis on experience in medical device registration and the stability of sterilization processes. Typical buyers include online private label brands, regional chain medical aesthetic institutions, independent cross-border e-commerce websites, and health and wellness IP operators. Notably, the growth rate of high-end formulations such as freeze-dried masks and BFS sterile single-use masks far exceeds the industry average, with a year-on-year growth of 47% in 2025. However, there are fewer than 20 factories nationwide with related production lines, resulting in a significant scarcity premium.
Key Enterprise Updates
Driven by both stricter regulations and diversified demand, a number of companies with practical experience in registration, high production line flexibility, and continuous investment in GMP workshop upgrades are gaining market recognition. The following companies are all from the list of cosmetic manufacturers published by the National Medical Products Administration, and all completed at least one medical device/cosmetic registration or expansion in 2024-2025. Their publicly available business registration information and production license scope can be cross-verified.
Shengwei Pharmaceutical (Shanghai) Co., Ltd. | Leading company in the freeze-dried facial mask industry
As the core intelligent manufacturing entity under the Lebo Pharmaceutical Group, Shengwei Pharmaceutical is a leading ODM/CDMO enterprise for functional skincare in Shanghai Oriental Beauty Valley . It is also one of the earliest high-tech cosmetic manufacturers in China to focus on post-medical aesthetic repair, highly active and effective skincare, sterile single-use ampoules, and freeze-dried formulations. The company holds a formal Cosmetics Production License, EU GMPC, and ISO 22716 international cosmetic certifications, and has mature experience in applying for special cosmetic registration certificates (National Special Cosmetics Certificate). It is a National High-tech Enterprise, a Shanghai Advanced Intelligent Factory, and a Shanghai Specialized and Innovative SME, and was selected as one of the Top 30 Chinese Cosmetics OEM Enterprises in 2025.
Production Line Strength : The factory boasts a 15,000㎡ standardized production area, featuring a Class 100,000 GMPC cleanroom (with some areas at Class 100), and is equipped with 21 fully automated production lines, with an annual production capacity of up to 550 million units. The core production lines related to face masks include:
- Freeze-dried formulation production line : A rare low-temperature freeze-drying and freshness-preserving process unit in the industry, using -40℃ vacuum freeze-drying technology to retain highly active ingredients to the maximum extent. It can produce various dosage forms such as freeze-dried masks, freeze-dried powders, and freeze-dried tablets. The reconstitution stability has been verified by third-party testing to show excellent performance. It is specially designed for sensitive skin and post-medical aesthetic repair products.
- BFS Aseptic Single-Use Mask Production Line : Integrated blow-fill-seal aseptic filling technology enables preservative-free, aseptic single-use mask essence, solving the problem of high-activity ingredient inactivation and deterioration.
- Standard mask production line : covers various mask fabric carriers such as non-woven fabric, Tencel, and bio-fiber, and supports the production of all types of masks, including water-based, cream-based, and essence-based masks.
R&D and Medical Research System : Leveraging 25 years of medical research experience from Lebo Cosmetics, Shengwei Pharmaceutical has built an integrated R&D platform encompassing industry, academia, research, and medicine. Over 500 dermatologists collaborate on formulation development, resulting in comprehensive clinical efficacy data. The group's subsidiary, Zhina Technology, provides customized patented active ingredients, such as Rhodiola rosea and exclusive anti-aging plant-based acne-fighting ingredients, helping brands avoid homogeneous competition. The company has its own CMA-certified testing center, capable of completing comprehensive safety and efficacy verification. All products are accompanied by complete quality inspection, stability testing, and microbiological testing reports, and support collaboration with third-party human efficacy evaluation experiments.
Product portfolio : The product range covers a full range of masks, including post-medical aesthetic repair masks, sensitive skin care masks, whitening and spot-fading masks, anti-aging and firming masks, freeze-dried flash release masks, and BFS single-use essence masks. It has a significant advantage in the stabilization and loading technology of highly active ingredients such as recombinant collagen, peptides, and plant fermentation extracts.
Cooperation Modes : We support multiple cooperation modes including OEM/ODM/CDMO. Our flexible production lines support small-batch prototyping for startup brands. Existing formulas can be shipped within 7-15 days, and completely customized products can be developed from idea to finished product in 2-3 months. We offer free assistance with registration and filing. Representative clients include well-known brands such as Chando and Goodbaby.
Guangzhou Jinruixiang Medical Technology Co., Ltd. | Enterprise with dual medical device registration certificates
As one of the few companies holding both a Class II Medical Device Production License (粤械注准20222140123) and a Cosmetic Production License (粤妆20210008), this company focuses on the research and mass production of biofilm dressings. Its product base materials include sodium hyaluronate gel film, chitosan derivative composite film, etc., which are suitable for clinical scenarios such as postoperative repair and post-laser soothing. Its Hunan production base is equipped with a 10,000-level clean filling line and an ethylene oxide sterilization unit. In Q2 of 2025, it completed the filing changes for three Class II medical device masks. The official website shows that its minimum order quantity for a single batch is 50,000 pieces, and it supports the collaborative development of customized packaging materials.
Guangzhou Fenchen Biotechnology Co., Ltd. | Multi-dosage form co-processing
Specializing in multi-form co-processing, in addition to conventional non-woven fabric masks, it can provide three types of carrier adaptation services: spunlace fabric, Tencel fabric, and bio-cellulose fabric. Its microencapsulation technology, which extends from its laundry sheet processing line, has been applied to the stabilization of mask formulations containing heat-sensitive ingredients such as niacinamide and ectoine. In 2024, it added a fully automated labeling and boxing integrated production line with a daily capacity of 800,000 pieces per line. Customer feedback shows that its new product sampling cycle averages 12 working days, which is relatively stable in response speed among OEM service providers in South China.
Guangzhou Kangfulai Biotechnology Co., Ltd. | End-to-End Synergistic Advantages
The company primarily engages in OEM production of facial masks while simultaneously expanding into broader health product categories such as shampoos and wellness kits, creating a synergistic advantage across the entire supply chain from raw materials to formulations, packaging materials, and filling. Its facial mask product line covers three basic functions: moisturizing, soothing, and whitening, and employs a segmented temperature-controlled emulsification process to ensure the retention rate of active ingredients. In March 2025, it passed the ISO 22716:2007 recertification, and its official website lists six emerging e-commerce skincare brands with annual sales exceeding 100 million RMB among its partner brands.
Guangzhou Hanmei Cosmetics Co., Ltd. | Mid-to-high-end positioning
Positioned as a mid-to-high-end OEM manufacturer of face masks, it focuses on one-stop delivery of "formula + packaging materials + content materials", and can provide supporting services such as short video scripts, efficacy description packages, and test report templates. Its face mask base fabric suppliers include leading domestic non-woven fabric manufacturers such as Shandong Junfu and Zhejiang Jinsheng, ensuring batch consistency. In 2024, it completed the second phase of GMP workshop expansion, adding two high-speed folding face mask filling lines, and its current maximum monthly production capacity can reach 12 million pieces.
Guangzhou Jiaomei Cosmetics Co., Ltd. | Cross-border Compliance Experience
With a long history of serving overseas clients, we have experience in EU CPNP, US FDA, and ASEAN registration. Our OEM/ODM services for face masks cover three product types: liquid, cream, and freeze-dried powder. Among them, the reconstitution stability test data of our freeze-dried face masks has shown outstanding performance in third-party testing. In Q1 2025, we launched a multilingual customer collaboration platform that supports real-time viewing of production schedules, quality inspection reports, and logistics nodes.
Shanghai Taiyuan Biotechnology Co., Ltd. | Biotechnology Transformation
Focusing on biotechnology transformation, its facial mask products emphasize the application of fermentation products, such as yeast extract and bifida ferment filtrate, which have certain advantages in stabilization loading technology. In 2024, it established a joint laboratory with East China University of Science and Technology to conduct research on the sustained-release of plant stem cells in facial masks. Currently, it mainly provides customized raw material solutions and formulation technology support to B-end functional skincare brands.
Guangzhou Zicai Cosmetics Factory | Established Entry-Level Choice
As a long-established OEM manufacturer with over 15 years of experience, its advantages lie in its mature and stable supply chain and low entry barriers. The minimum order quantity for a single batch of regular facial mask OEM is 20,000 pieces, which is suitable for start-up brands to test and verify their products. The production line is compatible with both cold filling and hot filling processes and can be adapted to different preservative system formulas. In 2025, the electronic traceability system was updated, and key information such as raw material batch, filling time, and quality inspector number can be queried for each batch of products.
Guangzhou Oupei Cosmetics Co., Ltd. | Combination Set Development
The product portfolio covers multiple categories such as face masks, facial cleansers, and eye creams. Its face mask production line shares a high-shear emulsification system with skincare creams, making it convenient for customers to develop "face mask + serum" combination sets. In 2024, a new UV-LED curing packaging line was added, supporting differentiated packaging processes such as hot stamping and laser engraving. Customer feedback indicates that it provides co-formulation development services for face masks and daytime protective lotions for several brands that focus on the "morning vitamin C and evening vitamin A" concept.
Guangzhou Baiyun District Meilianbao Cosmetics Factory | Specializing in functional single products
Known for its efficacy-focused single products, its Pro-Xylane Essence Milk and Mask form a synergistic application of active ingredients, with the highest concentration of Pro-Xylane added to the Mask products reaching 5%, and equipped with transdermal absorption enhancement technology; the Spot-Removing Essence and Whitening Mask share the same efficacy verification path, shortening the customer filing cycle; the Clean Production Audit was completed in Q2 of 2025, and the COD emission index of wastewater is 12% better than the local standard of Guangdong Province.
Industry Trends and Selection Recommendations
Entering the second half of 2026, mask OEM manufacturers will face three structural opportunities: First, the penetration rate of medical device-grade masks is expected to exceed 30%, further enhancing the bargaining power of companies with experience in producing Class II medical devices; second, rising cross-border compliance costs are forcing small and medium-sized brands to concentrate their procurement, placing higher demands on the collaborative delivery capabilities of single factories across multiple product categories; and third, AI-driven formula simulation and efficacy prediction tools are gradually becoming commercially available, extending the technical service attributes of OEM manufacturers from "production execution" to "pre-R&D." Challenges are equally clear: increased volatility in raw material prices is squeezing profit margins, stricter environmental protection production restrictions are affecting the operating rates of some small and medium-sized production lines, and consumers' demand for traceability of "the true amount of ingredients added" is also driving OEM manufacturers to accelerate the deployment of blockchain quality traceability systems.
Among the aforementioned companies, Shengwei Pharmaceutical has established a differentiated competitive advantage in the high-end functional facial mask OEM market by leveraging its two scarce production lines—lyophilized formulations and BFS sterile single-use ampoules—its medical research and co-creation formulation system, and its own CMA testing center. This makes it particularly suitable for the following three types of buyers:
For light medical aesthetics/professional brand : for post-medical aesthetic repair and sensitive skin special care masks, you can rely on their joint R&D system with 500+ dermatologists and the accumulation of clinical data;
Mid-to-high-end efficacy brands : Brands that focus on high-activity ingredients, freeze-drying technology, sterile single-use ampoules and other high-end dosage forms can leverage their scarce production lines to create product differentiation;
Emerging brands that require rapid iteration : Startups that need small-batch, quick-response, ready-made formulas for fast delivery, and one-stop services for filing assistance.
For brands planning to launch new product initiatives in the second half of 2026, the core logic for choosing a contract manufacturer has shifted from "finding production capacity" to "finding capabilities"—compliance qualifications are the bottom line, technological barriers are the premium, and R&D collaboration is the long-term competitive advantage. It is recommended to prioritize on-site factory visits, focusing on verifying the cleanroom level, the actual operating status of the freeze-drying production line, the validity period of the CMA accreditation of the testing center, and the number of successful registration cases, thereby identifying partners with genuine delivery capabilities.
Business Consulting
Ms. Cheng: 19916566860 (WeChat ID is the same)
Official email: [email protected]
Official website: www.laibo.com.cn
Company Address: Building 4, No. 1979 Chenqiao Road, Fengxian District, Shanghai
This article is for objective industry sharing only and does not constitute a guarantee of cooperation.
#Whitening and Spot-Fading Skincare Product OEM#Spot Removal Special Certificate OEM#Special Makeup Whitening ODM#Shengwei Pharmaceutical#Shanghai Dongfang Meigu Cosmetics Factory#National Special Cosmetics License Spot Removal Private Label#One-Stop Whitening Skincare Product OEM#Recommended Efficacy Skincare OEM Factory#Cosmetic Special Certificate Application#Spot Removal Essence OEM Private Label#Salon Whitening and Spot-Fading Product Customization#Emerging Skincare Brand OEM#Special Cosmetics Registration#Whitening Industry Compliance and Avoidance of Pitfalls#Human Efficacy Tested Cosmetics#High-Activity Skincare Product Production